Format
Sort by

Send to

Choose Destination

Search results

Items: 20

1.

Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: A Children's Oncology Group study.

Landier W, Chen Y, Hageman L, Kim H, Bostrom BC, Casillas JN, Dickens DS, Evans WE, Maloney KW, Mascarenhas L, Ritchey AK, Termuhlen AM, Carroll WL, Relling MV, Wong FL, Bhatia S.

Blood. 2017 Feb 2. pii: blood-2016-07-726893. doi: 10.1182/blood-2016-07-726893. [Epub ahead of print]

PMID:
28153823
2.

Transient juvenile myelomonocytic leukemia in the setting of PTPN11 mutation and Noonan syndrome with secondary development of monosomy 7.

O'Halloran K, Ritchey AK, Djokic M, Friehling E.

Pediatr Blood Cancer. 2017 Jan 13. doi: 10.1002/pbc.26408. [Epub ahead of print]

PMID:
28084675
3.

Management of type 2b von Willebrand disease in the neonatal period.

Proud L, Ritchey AK.

Pediatr Blood Cancer. 2017 Jan;64(1):103-105. doi: 10.1002/pbc.26168.

PMID:
27468167
4.

Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia.

Vrooman LM, Kirov II, Dreyer ZE, Kelly M, Hijiya N, Brown P, Drachtman RA, Messinger YH, Ritchey AK, Hale GA, Maloney K, Lu Y, Plourde PV, Silverman LB.

Pediatr Blood Cancer. 2016 Feb;63(2):228-33. doi: 10.1002/pbc.25757.

5.

Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study.

Bhatia S, Landier W, Hageman L, Chen Y, Kim H, Sun CL, Kornegay N, Evans WE, Angiolillo AL, Bostrom B, Casillas J, Lew G, Maloney KW, Mascarenhas L, Ritchey AK, Termuhlen AM, Carroll WL, Wong FL, Relling MV.

JAMA Oncol. 2015 Jun;1(3):287-95. doi: 10.1001/jamaoncol.2015.0245.

6.

Severe iron-deficiency anemia still an issue in toddlers.

Paoletti G, Bogen DL, Ritchey AK.

Clin Pediatr (Phila). 2014 Dec;53(14):1352-8. doi: 10.1177/0009922814540990.

PMID:
24990367
7.

6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study.

Bhatia S, Landier W, Hageman L, Kim H, Chen Y, Crews KR, Evans WE, Bostrom B, Casillas J, Dickens DS, Maloney KW, Neglia JP, Ravindranath Y, Ritchey AK, Wong FL, Relling MV.

Blood. 2014 Oct 9;124(15):2345-53. doi: 10.1182/blood-2014-01-552166.

8.

Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group.

Bhatia S, Landier W, Shangguan M, Hageman L, Schaible AN, Carter AR, Hanby CL, Leisenring W, Yasui Y, Kornegay NM, Mascarenhas L, Ritchey AK, Casillas JN, Dickens DS, Meza J, Carroll WL, Relling MV, Wong FL.

J Clin Oncol. 2012 Jun 10;30(17):2094-101. doi: 10.1200/JCO.2011.38.9924.

9.

Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions.

Shaw PH, Boyiadzis M, Tawbi H, Welsh A, Kemerer A, Davidson NE, Ritchey AK.

Cancer. 2012 Jul 15;118(14):3614-7. doi: 10.1002/cncr.26634.

10.

Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.

Blanco JG, Sun CL, Landier W, Chen L, Esparza-Duran D, Leisenring W, Mays A, Friedman DL, Ginsberg JP, Hudson MM, Neglia JP, Oeffinger KC, Ritchey AK, Villaluna D, Relling MV, Bhatia S.

J Clin Oncol. 2012 May 1;30(13):1415-21. doi: 10.1200/JCO.2011.34.8987.

11.

Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia.

Grace RF, Bennett CM, Ritchey AK, Jeng M, Thornburg CD, Lambert MP, Neier M, Recht M, Kumar M, Blanchette V, Klaassen RJ, Buchanan GR, Kurth MH, Nugent DJ, Thompson AA, Stine K, Kalish LA, Neufeld EJ.

Pediatr Blood Cancer. 2012 Feb;58(2):221-5. doi: 10.1002/pbc.23130.

12.

A cost-effectiveness analysis of coagulation testing prior to tonsillectomy and adenoidectomy in children.

Cooper JD, Smith KJ, Ritchey AK.

Pediatr Blood Cancer. 2010 Dec 1;55(6):1153-9. doi: 10.1002/pbc.22708.

PMID:
20672369
13.

Controversies in the management of central nervous system leukemia.

Barredo J, Ritchey AK.

Pediatr Hematol Oncol. 2010 Aug;27(5):329-32. doi: 10.3109/08880011003758422. Review.

PMID:
20469977
14.

Management of tumor lysis syndrome: need for evidence-based guidelines.

Feusner JH, Ritchey AK, Cohn SL, Billett AL.

J Clin Oncol. 2008 Dec 1;26(34):5657-8; author reply 5658-9. doi: 10.1200/JCO.2008.19.6030. No abstract available.

PMID:
18981455
15.

Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study.

Mulrooney DA, Dover DC, Li S, Yasui Y, Ness KK, Mertens AC, Neglia JP, Sklar CA, Robison LL, Davies SM; Childhood Cancer Survivor Study..

Cancer. 2008 May 1;112(9):2071-9. doi: 10.1002/cncr.23405.

16.

Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.

Barredo JC, Devidas M, Lauer SJ, Billett A, Marymont M, Pullen J, Camitta B, Winick N, Carroll W, Ritchey AK.

J Clin Oncol. 2006 Jul 1;24(19):3142-9.

PMID:
16809737
17.

Sirolimus rescue for tacrolimus-associated post-transplant autoimmune hemolytic anemia.

Valentini RP, Imam A, Warrier I, Ellis D, Ritchey AK, Ravindranath Y, Shapiro R, Moritz ML.

Pediatr Transplant. 2006 May;10(3):358-61.

PMID:
16677361
18.

A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).

O'Brien SH, Ritchey AK, Smith KJ.

Pediatr Blood Cancer. 2007 Feb;48(2):173-80.

PMID:
16550529
19.

Smallpox vaccination recommendations for contacts of pediatric cancer patients.

Sung L, Schwartz B, Abramson J, Greenberg DP, Edwards K, Feusner J, Allen U, Ritchey AK.

Pediatr Blood Cancer. 2004 Jul;43(1):4-7. No abstract available.

PMID:
15170883
20.
Items per page

Supplemental Content

Loading ...
Support Center